Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Is the Method of Screening in Sacral Neuromodulation a Prognostic Factor for Long-term Success?

NCT01130415 is registered in ClinicalTrials.gov with Maastricht University Medical Center as lead sponsor.

NCT NCT01130415
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01130415 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Is the Method of Screening in Sacral Neuromodulation a Prognostic Factor for Long-term Success?
Lead sponsor
Maastricht University Medical Center
Phase
Observational
Overall status
Completed
Start date
May 31, 2002
Completion date
July 31, 2009
Enrollment
64 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

overactive bladder, urinary retention